Published in Nature on December 22, 2005
Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev (2010) 11.25
Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol (2009) 6.90
White matter in learning, cognition and psychiatric disorders. Trends Neurosci (2008) 4.72
Myelination and support of axonal integrity by glia. Nature (2010) 3.54
Vesicular release of glutamate from unmyelinated axons in white matter. Nat Neurosci (2007) 3.39
Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science (2014) 3.11
Spiking and nonspiking classes of oligodendrocyte precursor glia in CNS white matter. Nat Neurosci (2008) 2.97
Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed (2008) 2.85
Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol (2013) 2.61
Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci (2011) 2.61
Donald Munro Lecture. Spinal cord injury--past, present, and future. J Spinal Cord Med (2007) 2.32
Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets (2007) 2.26
Regulation of NMDA receptors by phosphorylation. Neuropharmacology (2007) 2.20
Neuregulin and BDNF induce a switch to NMDA receptor-dependent myelination by oligodendrocytes. PLoS Biol (2013) 1.92
Oligodendrocytes: biology and pathology. Acta Neuropathol (2009) 1.81
Excitability and synaptic communication within the oligodendrocyte lineage. J Neurosci (2010) 1.74
Excitatory glycine responses of CNS myelin mediated by NR1/NR3 "NMDA" receptor subunits. J Neurosci (2010) 1.72
The role of neuronal complexes in human X-linked brain diseases. Am J Hum Genet (2007) 1.71
Regulation of oligodendrocyte development and myelination by glucose and lactate. J Neurosci (2011) 1.67
NG2-glia as multipotent neural stem cells: fact or fantasy? Neuron (2011) 1.67
Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction. Ann N Y Acad Sci (2010) 1.64
The energetics of CNS white matter. J Neurosci (2012) 1.63
The dichotomy of NMDA receptor signaling. Neuroscientist (2007) 1.61
Will the real multiple sclerosis please stand up? Nat Rev Neurosci (2012) 1.61
Activation of recombinant NR1/NR2C NMDA receptors. J Physiol (2008) 1.57
NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. J Neurosci (2008) 1.55
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog Neurobiol (2010) 1.54
The encephalopathy of prematurity--brain injury and impaired brain development inextricably intertwined. Semin Pediatr Neurol (2009) 1.51
Proton-gated Ca(2+)-permeable TRP channels damage myelin in conditions mimicking ischaemia. Nature (2016) 1.49
Astrocytes in Alzheimer's disease. Neurotherapeutics (2010) 1.47
The developing oligodendrocyte: key cellular target in brain injury in the premature infant. Int J Dev Neurosci (2011) 1.46
Progress in periventricular leukomalacia. Arch Neurol (2008) 1.46
Neuron-glia synapses in the brain. Brain Res Rev (2009) 1.45
A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors. Nat Commun (2010) 1.38
Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulation. Trends Mol Med (2010) 1.32
Pregabalin as a neuroprotector after spinal cord injury in rats. Eur Spine J (2008) 1.27
Neurotransmitter receptors in the life and death of oligodendrocytes. Neuroscience (2006) 1.24
NMDA receptor antibodies associated with distinct white matter syndromes. Neurol Neuroimmunol Neuroinflamm (2014) 1.22
Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists. J Med Chem (2010) 1.20
Novel regional and developmental NMDA receptor expression patterns uncovered in NR2C subunit-beta-galactosidase knock-in mice. Mol Cell Neurosci (2007) 1.20
Excitotoxic damage to white matter. J Anat (2007) 1.19
NMDA receptor signaling in oligodendrocyte progenitors is not required for oligodendrogenesis and myelination. J Neurosci (2011) 1.18
Glutamate excitotoxicity inflicts paranodal myelin splitting and retraction. PLoS One (2009) 1.17
Neurobiology of injury to the developing brain. Nat Rev Neurol (2010) 1.16
Ca(2+) signaling evoked by activation of Na(+) channels and Na(+)/Ca(2+) exchangers is required for GABA-induced NG2 cell migration. J Cell Biol (2009) 1.14
Influence of the NR3A subunit on NMDA receptor functions. Prog Neurobiol (2010) 1.14
A new mechanism of nervous system plasticity: activity-dependent myelination. Nat Rev Neurosci (2015) 1.13
Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors. Ann Neurol (2009) 1.12
Glutamate and ATP signalling in white matter pathology. J Anat (2011) 1.11
Non-synaptic receptors and transporters involved in brain functions and targets of drug treatment. Br J Pharmacol (2010) 1.11
Genome-wide association study of severity in multiple sclerosis. Genes Immun (2011) 1.10
Testing NMDA receptor block as a therapeutic strategy for reducing ischaemic damage to CNS white matter. Glia (2008) 1.10
Chronic progressive multiple sclerosis - pathogenesis of neurodegeneration and therapeutic strategies. Curr Neuropharmacol (2010) 1.10
Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms. Ann Neurol (2014) 1.08
Opiate drug use and the pathophysiology of neuroAIDS. Curr HIV Res (2012) 1.07
Morphological and electrical properties of oligodendrocytes in the white matter of the corpus callosum and cerebellum. J Physiol (2010) 1.07
White matter astrocytes in health and disease. Neuroscience (2013) 1.07
Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models. Clin Schizophr Relat Psychoses (2010) 1.06
Oligovascular signaling in white matter stroke. Biol Pharm Bull (2009) 1.06
N-methyl-D-aspartate (NMDA) receptor NR2 subunit selectivity of a series of novel piperazine-2,3-dicarboxylate derivatives: preferential blockade of extrasynaptic NMDA receptors in the rat hippocampal CA3-CA1 synapse. J Pharmacol Exp Ther (2009) 1.05
Synapses on NG2-expressing progenitors in the brain: multiple functions? J Physiol (2008) 1.03
A putative functional role for oligodendrocytes in mood regulation. Transl Psychiatry (2012) 1.02
Distinct pharmacological and functional properties of NMDA receptors in mouse cortical astrocytes. Br J Pharmacol (2011) 1.01
Glutamate-mediated neuronal-glial transmission. J Anat (2007) 1.01
Pathophysiology of glia in perinatal white matter injury. Glia (2014) 1.00
Combining patch-clamping of cells in brain slices with immunocytochemical labeling to define cell type and developmental stage. Nat Protoc (2006) 1.00
Oligodendrocyte differentiation from adult multipotent stem cells is modulated by glutamate. Cell Death Dis (2012) 0.99
High yields of oligodendrocyte lineage cells from human embryonic stem cells at physiological oxygen tensions for evaluation of translational biology. Stem Cell Reports (2013) 0.99
Neuroprotection in the newborn infant. Clin Perinatol (2009) 0.99
Vesicular apparatus, including functional calcium channels, are present in developing rodent optic nerve axons and are required for normal node of Ranvier formation. J Physiol (2008) 0.98
Morphological and physiological interactions of NG2-glia with astrocytes and neurons. J Anat (2007) 0.96
Selective Vulnerabilities of N-methyl-D-aspartate (NMDA) Receptors During Brain Aging. Front Aging Neurosci (2010) 0.95
HDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammation. Am J Transl Res (2014) 0.95
Characterization of acid-sensing ion channel expression in oligodendrocyte-lineage cells. Glia (2008) 0.95
Disruption of NMDA receptors in oligodendroglial lineage cells does not alter their susceptibility to experimental autoimmune encephalomyelitis or their normal development. J Neurosci (2012) 0.95
The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes. Brain (2009) 0.94
Oligodendrocytes changing the rules: action potentials in glia and oligodendrocytes controlling action potentials. Neuroscientist (2008) 0.94
Oligodendrocyte-microglia cross-talk in the central nervous system. Immunology (2014) 0.93
Relapsing and progressive forms of multiple sclerosis: insights from pathology. Curr Opin Neurol (2014) 0.92
Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1alpha truncation. Exp Neurol (2009) 0.92
Regulation of glutamate transport in developing rat oligodendrocytes. J Neurosci (2009) 0.92
NMDA Receptors in Glial Cells: Pending Questions. Curr Neuropharmacol (2013) 0.92
Complex interplay between glutamate receptors and intracellular Ca2+ stores during ischaemia in rat spinal cord white matter. J Physiol (2006) 0.91
Magnitude of [(11)C]PK11195 binding is related to severity of motor deficits in a rabbit model of cerebral palsy induced by intrauterine endotoxin exposure. Dev Neurosci (2011) 0.91
Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain. Cereb Cortex (2013) 0.91
Supralinear potentiation of NR1/NR3A excitatory glycine receptors by Zn2+ and NR1 antagonist. Proc Natl Acad Sci U S A (2008) 0.91
Hypoxic injury of isolated axons is independent of ionotropic glutamate receptors. Neurobiol Dis (2006) 0.91
Disruption of ionic and cell volume homeostasis in cerebral ischemia: The perfect storm. Pathophysiology (2007) 0.90
Metabolic aspects of neuron-oligodendrocyte-astrocyte interactions. Front Endocrinol (Lausanne) (2013) 0.90
Regulated release of BDNF by cortical oligodendrocytes is mediated through metabotropic glutamate receptors and the PLC pathway. ASN Neuro (2009) 0.90
Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator. Mol Pharmacol (2014) 0.89
Unraveling the secrets of white matter--bridging the gap between cellular, animal and human imaging studies. Neuroscience (2014) 0.89
Experimental models for analysis of oligodendrocyte pathophysiology in stroke. Exp Transl Stroke Med (2009) 0.89
Ionic regulation of cell volume changes and cell death after ischemic stroke. Transl Stroke Res (2013) 0.88
The receptor subunits generating NMDA receptor mediated currents in oligodendrocytes. J Physiol (2010) 0.88
Derivation of glial restricted precursors from E13 mice. J Vis Exp (2012) 0.87
Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity. Front Cell Dev Biol (2014) 0.87
Lactate transport and signaling in the brain: potential therapeutic targets and roles in body-brain interaction. J Cereb Blood Flow Metab (2014) 0.87
Pregabalin as a neuroprotector after spinal cord injury in rats: biochemical analysis and effect on glial cells. J Korean Med Sci (2011) 0.86
Diffuse axonal damage, myelin impairment, astrocytosis and inflammatory response following microinjections of NMDA into the rat striatum. Inflammation (2007) 0.86
Glutamate neurotoxicity and diseases of the nervous system. Neuron (1988) 8.26
Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res (2001) 3.88
Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature (2000) 3.70
Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci (2001) 3.53
Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med (2000) 3.20
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature (2005) 2.92
Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med (2000) 2.34
NBQX attenuates excitotoxic injury in developing white matter. J Neurosci (2000) 2.11
Multiple structural elements determine subunit specificity of Mg2+ block in NMDA receptor channels. J Neurosci (1996) 2.05
NG2-positive cells in the mouse white and grey matter display distinct physiological properties. J Physiol (2004) 1.91
Characterization and comparison of the NR3A subunit of the NMDA receptor in recombinant systems and primary cortical neurons. J Neurophysiol (2002) 1.87
Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J Neurosci (1993) 1.86
Oligodendrocytes and ischemic brain injury. J Cereb Blood Flow Metab (2003) 1.85
A role for glutamate and its receptors in the regulation of oligodendrocyte development in cerebellar tissue slices. Development (1998) 1.82
Ampa/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J Neurosci (2001) 1.71
White matter injury mechanisms. Curr Mol Med (2004) 1.65
The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci (2001) 1.62
Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptor. Neuron (1994) 1.58
A preferential role for glycolysis in preventing the anoxic depolarization of rat hippocampal area CA1 pyramidal cells. J Neurosci (2005) 1.37
Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury. J Neurosci (1997) 1.33
Cytology and lineage of NG2-positive glia. J Neurocytol (2003) 1.17
Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma. Exp Neurol (1997) 1.16
GABA- and glutamate-activated currents in glial cells of the mouse corpus callosum slice. J Neurosci Res (1992) 1.13
Early postnatal switch in magnesium sensitivity of NMDA receptors in rat CA1 pyramidal cells. J Physiol (1999) 1.07
Functional N-methyl-D-aspartate receptors in O-2A glial precursor cells: a critical role in regulating polysialic acid-neural cell adhesion molecule expression and cell migration. J Cell Biol (1996) 1.06
Glutamate-, kainate- and NMDA-evoked membrane currents in identified glial cells in rat spinal cord slice. Physiol Res (1998) 1.03
Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis. J Neurol Sci (1996) 1.01
The N-methyl-D-aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats. Stroke (2000) 0.95
Blockade of K+ channels induced by AMPA/kainate receptor activation in mouse oligodendrocyte precursor cells is mediated by Na+ entry. J Neurosci Res (1995) 0.87
Bidirectional control of CNS capillary diameter by pericytes. Nature (2006) 5.27
Glutamate exocytosis from astrocytes controls synaptic strength. Nat Neurosci (2007) 4.43
Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses. Neuron (2009) 3.49
Do astrocytes really exocytose neurotransmitters? Nat Rev Neurosci (2010) 3.17
Spiking and nonspiking classes of oligodendrocyte precursor glia in CNS white matter. Nat Neurosci (2008) 2.97
Tonic and spillover inhibition of granule cells control information flow through cerebellar cortex. Neuron (2002) 2.47
Synaptic energy use and supply. Neuron (2012) 2.40
Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling. Neuron (2013) 2.33
Multiple modes of GABAergic inhibition of rat cerebellar granule cells. J Physiol (2003) 1.88
Updated energy budgets for neural computation in the neocortex and cerebellum. J Cereb Blood Flow Metab (2012) 1.81
The LIM protein Ajuba is recruited to cadherin-dependent cell junctions through an association with alpha-catenin. J Biol Chem (2002) 1.70
Regulation of oligodendrocyte development and myelination by glucose and lactate. J Neurosci (2011) 1.67
Expression of the vesicular glutamate transporters during development indicates the widespread corelease of multiple neurotransmitters. J Comp Neurol (2004) 1.67
The energetics of CNS white matter. J Neurosci (2012) 1.63
Pericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and disease. Front Neuroenergetics (2010) 1.59
Cellular and subcellular distribution of monocarboxylate transporters in cultured brain cells and in the adult brain. J Neurosci Res (2004) 1.56
Tonic release of glutamate by a DIDS-sensitive mechanism in rat hippocampal slices. J Physiol (2005) 1.50
Oxidative phosphorylation, not glycolysis, powers presynaptic and postsynaptic mechanisms underlying brain information processing. J Neurosci (2012) 1.47
A preferential role for glycolysis in preventing the anoxic depolarization of rat hippocampal area CA1 pyramidal cells. J Neurosci (2005) 1.37
Endocannabinoid signaling depends on the spatial pattern of synapse activation. Nat Neurosci (2005) 1.30
The physiology of developmental changes in BOLD functional imaging signals. Dev Cogn Neurosci (2011) 1.26
Properties and fate of oligodendrocyte progenitor cells in the corpus callosum, motor cortex, and piriform cortex of the mouse. J Neurosci (2012) 1.24
Modulation of ASIC channels in rat cerebellar Purkinje neurons by ischaemia-related signals. J Physiol (2002) 1.24
Tonic excitation and inhibition of neurons: ambient transmitter sources and computational consequences. Prog Biophys Mol Biol (2005) 1.24
The role of glial glutamate transporters in maintaining the independent operation of juvenile mouse cerebellar parallel fibre synapses. J Physiol (2003) 1.14
Testing NMDA receptor block as a therapeutic strategy for reducing ischaemic damage to CNS white matter. Glia (2008) 1.10
Control of intracellular chloride concentration and GABA response polarity in rat retinal ON bipolar cells. J Physiol (2002) 1.08
Morphological and electrical properties of oligodendrocytes in the white matter of the corpus callosum and cerebellum. J Physiol (2010) 1.07
Short- and long-term depression of rat cerebellar parallel fibre synaptic transmission mediated by synaptic crosstalk. J Physiol (2006) 1.07
Role of glial amino acid transporters in synaptic transmission and brain energetics. Glia (2004) 1.06
The ionic stoichiometry of the GLAST glutamate transporter in salamander retinal glia. J Physiol (2006) 1.06
Sequential release of GABA by exocytosis and reversed uptake leads to neuronal swelling in simulated ischemia of hippocampal slices. J Neurosci (2004) 1.06
The energy use associated with neural computation in the cerebellum. J Cereb Blood Flow Metab (2009) 1.04
Assessing the physiological concentration and targets of nitric oxide in brain tissue. J Physiol (2008) 1.03
Combining patch-clamping of cells in brain slices with immunocytochemical labeling to define cell type and developmental stage. Nat Protoc (2006) 1.00
The electrical response of cerebellar Purkinje neurons to simulated ischaemia. Brain (2005) 0.98
Hippocampal adult neurogenesis is maintained by Neil3-dependent repair of oxidative DNA lesions in neural progenitor cells. Cell Rep (2012) 0.97
Neurotransmitter depletion by bafilomycin is promoted by vesicle turnover. Neurosci Lett (2006) 0.97
The effect of simulated ischaemia on spontaneous GABA release in area CA1 of the juvenile rat hippocampus. J Physiol (2004) 0.97
The node of Ranvier in CNS pathology. Acta Neuropathol (2014) 0.97
The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes. Brain (2009) 0.94
Electrical signalling properties of oligodendrocyte precursor cells. Neuron Glia Biol (2009) 0.93
A role for glutamate transporters in the regulation of insulin secretion. PLoS One (2011) 0.92
Mitochondrial DNA toxicity in forebrain neurons causes apoptosis, neurodegeneration, and impaired behavior. Mol Cell Biol (2010) 0.92
Monocarboxylate transporter 1 is deficient on microvessels in the human epileptogenic hippocampus. Neurobiol Dis (2010) 0.91
Neurobiology: feeding the brain. Nature (2004) 0.90
Active release of glycine or D-serine saturates the glycine site of NMDA receptors at the cerebellar mossy fibre to granule cell synapse. Eur J Neurosci (2003) 0.90
The amino terminus of the glial glutamate transporter GLT-1 interacts with the LIM protein Ajuba. Mol Cell Neurosci (2002) 0.89
Knocking out the glial glutamate transporter GLT-1 reduces glutamate uptake but does not affect hippocampal glutamate dynamics in early simulated ischaemia. Eur J Neurosci (2002) 0.89
Reversal or reduction of glutamate and GABA transport in CNS pathology and therapy. Pflugers Arch (2004) 0.89
The role of pannexin hemichannels in the anoxic depolarization of hippocampal pyramidal cells. Brain (2010) 0.89
The receptor subunits generating NMDA receptor mediated currents in oligodendrocytes. J Physiol (2010) 0.88
Evidence for astrocytes as a potential source of the glutamate excess in temporal lobe epilepsy. Neurobiol Dis (2012) 0.86
The cortical energy needed for conscious perception. Neuroimage (2008) 0.84
Oxygen consumption and blood flow coupling in human motor cortex during intense finger tapping: implication for a role of lactate. J Cereb Blood Flow Metab (2012) 0.83
Mitochondrial DNA toxicity compromises mitochondrial dynamics and induces hippocampal antioxidant defenses. DNA Repair (Amst) (2011) 0.83
Death and survival of heterozygous Lurcher Purkinje cells in vitro. Dev Neurobiol (2009) 0.83
Altered expression of brain monocarboxylate transporter 1 in models of temporal lobe epilepsy. Neurobiol Dis (2011) 0.82
Why do oligodendrocyte lineage cells express glutamate receptors? F1000 Biol Rep (2010) 0.82
Alterations of monocarboxylate transporter densities during hypoxia in brain and breast tumour cells. Cell Oncol (Dordr) (2012) 0.82
Charge compensation for NADPH oxidase activity in microglia in rat brain slices does not involve a proton current. Eur J Neurosci (2008) 0.82
Release of L-aspartate by reversal of glutamate transporters. Neuropharmacology (2005) 0.81
Neuroscience: The wrap that feeds neurons. Nature (2012) 0.81
Monocarboxylate transporters in temporal lobe epilepsy: roles of lactate and ketogenic diet. Brain Struct Funct (2013) 0.81
Synapsin- and actin-dependent frequency enhancement in mouse hippocampal mossy fiber synapses. Cereb Cortex (2008) 0.80
Gene expression of glutamate metabolizing enzymes in the hippocampal formation in human temporal lobe epilepsy. Epilepsia (2012) 0.79
Natural selection of mitochondria during somatic lifetime promotes healthy aging. Front Neuroenergetics (2013) 0.79
The glia doctrine: addressing the role of glial cells in healthy brain ageing. Mech Ageing Dev (2013) 0.79
An astrocyte TRP switch for inhibition. Nat Neurosci (2011) 0.78
Increased expression of monocarboxylate transporter 1 after acute ischemia of isolated, perfused mouse hearts. Life Sci (2009) 0.78
Redistribution of monocarboxylate transporter 2 on the surface of astrocytes in the human epileptogenic hippocampus. Glia (2012) 0.78
Is myelin a mitochondrion? J Cereb Blood Flow Metab (2012) 0.78
Neuroscience: Brain power. Nature (2008) 0.77
DNA damage response, bioenergetics, and neurological disease: the challenge of maintaining brain health in an aging human population. Mech Ageing Dev (2013) 0.76
Unaltered lactate and glucose transporter levels in the MPTP mouse model of Parkinson's disease. J Parkinsons Dis (2013) 0.76
Transports of delight. Neuron (2006) 0.75
Corrigendum: Astrocytes mediate neurovascular signaling to capillary pericytes but not to arterioles. Nat Neurosci (2017) 0.75